Clinical outcome and adherence rate in Scandinavian patients with intermediate-intensity prophylaxis before and after the switch of standard half-life FVIII products to BAY 81-8973.

Alexandros ArvanitakisPål Andre HolmeErik Berntorp Jan Astermark

Published in: Haemophilia : the official journal of the World Federation of Hemophilia (2022)

Concentrate switch, using mainly intermediate-intensity regimens with high adherence rates, preserves excellent prophylaxis outcome using standard half-life FVIII products, indicating the value of individualized prophylaxis and close follow-up.

Keyphrases

high intensity
metabolic syndrome
weight loss
water quality